🏛️ Verified NIH Record • Updated 2026-05-21

Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy (NCT03582774)

Phase III Randomized Multicenter Trial of 68Ga-PSMA-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]

🔵 Active, Not Recruiting Phase3 🩺 Clinical Procedure Protocol Sponsor: Jonsson Comprehensive Cancer Center

🩺 Plain-English Summary (8th-Grade Level)

This phase III trial studies how well Gallium Ga 68-labeled PSMA-11 (68Ga-PSMA-11) positron emission tomography (PET)/computed tomography (CT) works in diagnosing participants with prostate cancer that has come back after surgery. 68Ga-PSMA-11 are taken up by cancer cells. Diagnostic procedures, such as PET/CT scans, may help find and diagnose prostate cancer and find out how far the disease has spread. Giving 68Ga-PSMA-11 with PET/CT may help doctors plan better for salvage radiation therapy in participants with recurrent prostate cancer.

Who can join: Review the eligibility criteria below.

Location: UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California

🧪 Interventions in This Study

  • Best Practice (OTHER)
  • Computed Tomography (PROCEDURE)
  • Gallium Ga 68-labeled PSMA-11 (RADIATION)
  • Positron Emission Tomography (PROCEDURE)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

  • UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
  • UCSF Medical Center-Mount Zion — San Francisco, California

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Recurrent Prostate Carcinoma

Explore by condition: All Recurrent Prostate Carcinoma clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗